Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

AtriCure (ATRC) Shares Issued (2016 - 2025)

AtriCure (ATRC) has disclosed Shares Issued for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

Quarterly Shares Issued rose 144.87% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, up 479.55% year-over-year, with the annual reading at $5.9 million for FY2025, 479.55% up from the prior year.
Shares Issued for Q4 2025 was $1.3 million at AtriCure, up from $392000.0 in the prior quarter.
The five-year high for Shares Issued was $4.6 million in Q1 2021, with the low at -$5.8 million in Q4 2021.
Average Shares Issued over 5 years is $1.0 million, with a median of $495000.0 recorded in 2022.
The sharpest move saw Shares Issued tumbled 835.31% in 2024, then surged 493.94% in 2025.
Over 5 years, Shares Issued stood at -$5.8 million in 2021, then skyrocketed by 108.02% to $468000.0 in 2022, then fell by 17.09% to $388000.0 in 2023, then crashed by 835.31% to -$2.9 million in 2024, then surged by 144.87% to $1.3 million in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $1.3 million, $392000.0, and $4.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.